相似文献
1
Target-induced formation of neuraminidase inhibitors from in vitro virtual combinatorial libraries.
Proc Natl Acad Sci U S A. 2002 Mar 19;99(6):3382-7. doi: 10.1073/pnas.052703799. Epub 2002 Mar 12.
2
Ketones as building blocks for dynamic combinatorial libraries: highly active neuraminidase inhibitors generated via selection pressure of the biological target.
J Med Chem. 2003 Jan 30;46(3):356-8. doi: 10.1021/jm025589m.
3
Influenza neuraminidase inhibitors: structure-based design of a novel inhibitor series.
Biochemistry. 2003 Jan 28;42(3):718-27. doi: 10.1021/bi0205449.
4
Combinatorial design of avian influenza neuraminidase inhibitors containing pyrrolidine core with a reduced susceptibility to viral drug resistance.
Comb Chem High Throughput Screen. 2010 Mar;13(3):268-77. doi: 10.2174/138620710790980504.
5
Design and synthesis of 6-oxo-1,4,5,6-tetrahydropyrimidine-5-carboxylate derivatives as neuraminidase inhibitors.
Eur J Med Chem. 2014 Aug 18;83:466-73. doi: 10.1016/j.ejmech.2014.06.059. Epub 2014 Jun 26.
6
Novel aromatic inhibitors of influenza virus neuraminidase make selective interactions with conserved residues and water molecules in the active site.
J Mol Biol. 1999 Nov 12;293(5):1107-19. doi: 10.1006/jmbi.1999.3180.
7
Drug screening for influenza neuraminidase inhibitors.
Sci China C Life Sci. 2005 Feb;48(1):1-5. doi: 10.1360/062004-69.
8
QSAR analyses on avian influenza virus neuraminidase inhibitors using CoMFA, CoMSIA, and HQSAR.
J Comput Aided Mol Des. 2006 Sep;20(9):549-66. doi: 10.1007/s10822-006-9080-0. Epub 2006 Nov 11.
9
Binding interaction analysis of the active site and its inhibitors for neuraminidase (N1 subtype) of human influenza virus by the integration of molecular docking, FMO calculation and 3D-QSAR CoMFA modeling.
J Chem Inf Model. 2008 Sep;48(9):1802-12. doi: 10.1021/ci800041k. Epub 2008 Aug 16.
10
Dihydropyrancarboxamides related to zanamivir: a new series of inhibitors of influenza virus sialidases. 2. Crystallographic and molecular modeling study of complexes of 4-amino-4H-pyran-6-carboxamides and sialidase from influenza virus types A and B.
J Med Chem. 1998 Mar 12;41(6):798-807. doi: 10.1021/jm9703754.
引用本文的文献
1
Auto In Silico Ligand Directing Evolution to Facilitate the Rapid and Efficient Discovery of Drug Lead.
iScience. 2020 Jun 26;23(6):101179. doi: 10.1016/j.isci.2020.101179. Epub 2020 May 18.
2
Proteintemplat-gesteuerte Fragmentligationen - von der molekularen Erkennung zur Wirkstofffindung.
Angew Chem Weinheim Bergstr Ger. 2017 Jun 19;129(26):7464-7485. doi: 10.1002/ange.201610372. Epub 2017 May 31.
3
Guest Binding Drives Host Redistribution in Libraries of Co L Cages.
Angew Chem Int Ed Engl. 2020 Jul 6;59(28):11369-11373. doi: 10.1002/anie.202004627. Epub 2020 May 7.
4
Optimized Inhibitors of MDM2 via an Attempted Protein-Templated Reductive Amination.
ChemMedChem. 2020 Feb 17;15(4):370-375. doi: 10.1002/cmdc.201900574. Epub 2019 Dec 12.
5
Source of oseltamivir resistance due to single E119D and double E119D/H274Y mutations in pdm09H1N1 influenza neuraminidase.
J Comput Aided Mol Des. 2020 Jan;34(1):27-37. doi: 10.1007/s10822-019-00251-7. Epub 2019 Nov 26.
6
Tailored therapeutics based on 1,2,3-1-triazoles: a mini review.
Medchemcomm. 2019 May 14;10(8):1302-1328. doi: 10.1039/c9md00218a. eCollection 2019 Aug 1.
7
Discovery of potent inhibitors of human β-tryptase from pre-equilibrated dynamic combinatorial libraries.
Chem Sci. 2015 Mar 1;6(3):1792-1800. doi: 10.1039/c4sc02943g. Epub 2014 Dec 8.
8
Protein-Templated Fragment Ligations-From Molecular Recognition to Drug Discovery.
Angew Chem Int Ed Engl. 2017 Jun 19;56(26):7358-7378. doi: 10.1002/anie.201610372. Epub 2017 May 31.
9
Protein-Directed Dynamic Combinatorial Chemistry: A Guide to Protein Ligand and Inhibitor Discovery.
Molecules. 2016 Jul 16;21(7):910. doi: 10.3390/molecules21070910.
10
Dynamic thiol exchange with β-sulfido-α,β-unsaturated carbonyl compounds and dithianes.
Org Lett. 2012 Sep 21;14(18):4714-7. doi: 10.1021/ol301781u. Epub 2012 Aug 30.
本文引用的文献
1
Strategies for the Dynamic Integration of Combinatorial Synthesis and Screening.
Angew Chem Int Ed Engl. 1998 Nov 2;37(20):2828-2831. doi: 10.1002/(SICI)1521-3773(19981102)37:20<2828::AID-ANIE2828>3.0.CO;2-G.
2
Using an Enzyme's Active Site To Template Inhibitors This work was supported by the Centre National de la Recherche Scientifique and by the Ecole Polytechnique (predoctoral fellowship to R.N.). We thank Prof. Jean-Marie Lehn for stimulating discussions.
Angew Chem Int Ed Engl. 2001 May 4;40(9):1774-1776.
3
Dynamic combinatorial chemistry.
Comb Chem High Throughput Screen. 2001 Feb;4(1):53-74. doi: 10.2174/1386207013331273.
4
Dynamic combinatorial chemistry.
Science. 2001 Mar 23;291(5512):2331-2. doi: 10.1126/science.1060066.
5
A novel approach to antiviral therapy for influenza.
J Antimicrob Chemother. 1999 Nov;44 Suppl B:17-22. doi: 10.1093/jac/44.suppl_2.17.
6
Molecular evolution: dynamic combinatorial libraries, autocatalytic networks and the quest for molecular function.
Curr Opin Chem Biol. 2000 Jun;4(3):270-9. doi: 10.1016/s1367-5931(00)00088-0.
7
Target-oriented and diversity-oriented organic synthesis in drug discovery.
Science. 2000 Mar 17;287(5460):1964-9. doi: 10.1126/science.287.5460.1964.
8
Discovery and development of GS 4104 (oseltamivir): an orally active influenza neuraminidase inhibitor.
Curr Med Chem. 2000 Jun;7(6):663-72. doi: 10.2174/0929867003374886.
9
Neuraminidase inhibitors as anti-influenza virus agents.
Antivir Chem Chemother. 1999 Jul;10(4):141-54. doi: 10.1177/095632029901000401.
10
Dynamic combinatorial chemistry: evolutionary formation and screening of molecular libraries.
Curr Top Microbiol Immunol. 1999;243:159-72. doi: 10.1007/978-3-642-60142-2_9.
Zotero 插件